Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cardiac effects of oxytocin during cesarean section
2004-004929-99Phase 4Completed
- Sponsor
- Uppsala University
- Start
- Dec 2004
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of oxytocin, sponsored by Uppsala University. Primary endpoints: Cardiac effects of oxytocin and Electrocardiographic changes. Started Dec 2004; status: completed.
02
Drugs
oxytocin
Beyond the preview
Go deeper on 2004-004929-99.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-004929-99.